Clinical Trials List
Protocol NumberCKAZ954A12101
Completed
2020-03-02 - 2023-09-15
Phase I
Not yet recruiting1
-
Trial Applicant
NOVARTIS (TAIWAN) CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- Chih-Hung Hsu 無
- 郭弘揚 無
- Kun-Huei Yeh 無
- Ann-Lii Cheng 無
- 梁逸歆 無
- Chiun Hsu 無
- TA-CHEN HUANG 無
- SHIH-HUNG YANG 未分科
- 陳國興 無
- JHE-CYUAN GUO 無
- SHIH-HUNG YANG 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
15-25 participants
-
Global
210 participants
